Injection site bruising on GLP-1s and peptides: what's real

What did @simplymyglp1journ actually say?

The creator is dealing with bruising and welts specifically on her thighs after subcutaneous injections, and she suspects her muscle density is the issue. She says her thighs are "pretty much solid, solid" while the rest of her body is "pretty much fatty," and she is rotating injection sites across legs, arms, and abdomen. She injects at a 45-degree angle and goes "super, super, super slow" to avoid burning. She is currently using CJC-1295 with ipamorelin, tirzepatide, NAD, and something she calls "Cloe" (likely BPC-157 or another peptide, unclear from context). Her question is whether she is doing something technically wrong, or whether the thigh site is simply not ideal for her body composition.

She is not making dramatic health claims here. This is a practical injection technique question, which is actually refreshing compared to most peptide content online.

Does the science back this up?

Yes, substantially. Injecting into a more muscular site when you are aiming for subcutaneous delivery is a well-documented source of injection-site complications. The concern is real, not imagined.

Subcutaneous injections are designed to deposit medication into the adipose (fat) layer beneath the skin, not into muscle. When the fat layer is thin, particularly in the anterolateral thigh, a needle can inadvertently enter the muscle fascia or intramuscular tissue. Intramuscular delivery of agents designed for subcutaneous absorption causes localized inflammation, which presents as welts, bruising, or hematoma formation. A 2019 review by Thow et al. in Practical Diabetes specifically examined injection technique in lean and muscular patients and found that shorter needles at 90-degree angles performed better in low-adipose sites than longer needles at angled approaches. The thigh's vastus lateralis muscle sits quite close to the skin surface in muscular individuals, making subcutaneous clearance harder to guarantee. Needle length matters enormously here, and that variable is conspicuously absent from her troubleshooting.

What did they get wrong (or right)?

She got the core anatomy observation right: muscular thighs are a genuinely harder subcutaneous injection site. Credit where it is due.

What she is missing is needle length as a variable. Injecting at 45 degrees with a needle that is too long for her tissue depth can cause the tip to penetrate muscle regardless of angle or speed. The injection speed, while it can affect comfort, is unlikely to be the primary driver of bruising. Bruising typically comes from nicking small capillaries during needle insertion or withdrawal, not from infusion rate. Her assumption that slow injection prevents welts is partly off, though it does reduce pressure-related discomfort.

She also mentions avoiding the inner thigh because it is "more sensitive," which is correct for a different reason: the medial thigh has higher nerve density and is not a standard subcutaneous injection site. That instinct is sound. However, her current lateral thigh approach may still be hitting insufficient fat depth. The standard recommendation from the Forum for Injection Technique (FIT, 2016 guidelines) is to use a skin fold lift technique in low-adipose areas, which she does not mention using.

What should you actually know?

If you are injecting subcutaneously into a muscular thigh, needle length and skin fold technique are the two variables most likely to solve this problem, not injection speed.

For individuals with low subcutaneous fat at the injection site, the FIT guidelines (Frid et al., 2016, Mayo Clinic Proceedings) recommend lifting a skin fold before injecting to mechanically separate the subcutaneous layer from muscle, then injecting at 90 degrees with a short needle (4mm or 6mm pen needle equivalents). A 45-degree angle was designed to help when you cannot use a skin fold, but it requires calibrated needle length for the tissue depth available. If the needle is too long relative to available fat, you hit muscle at any angle.

Bruising specifically often comes from blood vessel disruption. Rotating sites more frequently, avoiding areas with visible surface veins, and applying gentle pressure post-injection (without rubbing) can reduce incidence. Some practitioners suggest icing the site briefly before injection to cause vasoconstriction, though evidence for this is observational rather than from controlled trials.

One more thing worth saying plainly: this creator is self-administering multiple compounds simultaneously, including at least two peptides, tirzepatide, and NAD. That is a complex stack. The interaction between these compounds at the injection site, and systemically, is not something with robust clinical trial data. Anyone doing this should be working with a licensed prescriber who is actively monitoring them, not just crowd-sourcing injection tips on TikTok.